Mirabig 50mg Tablet ER
Marketer
MSN Laboratories
Salt Composition
Mirabegron (50mg)
Overview Mirabig 50mg Tablet ER
Extended-release Mirabig 50mg tablets manage overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always follow your doctor's prescribed dosage and duration; it can be taken with or without food. Swallow the tablet whole—do not crush or chew. Discontinue use only after consulting your physician, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Possible side effects include constipation, headache, hypertension, nasal congestion, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects to your doctor promptly. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their physician.
Primary Ingredients of Mirabig 50mg Tablet ER
The provided text is "undefined," so there is nothing to rephrase.
Uses of Mirabig 50mg Tablet ER
Managing overactive bladder (OAB) symptoms
Major Benefits of Mirabig 50mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Mirabig 50mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Mirabig 50mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Mirabig 50mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Mirabig 50mg Extended-Release Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While Mirabig 50mg ER can be administered with or without food, consistent timing is recommended.
How Mirabig 50mg Tablet ER works:
Extended-release Mirabig 50mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves stimulating bladder beta-3 receptors, resulting in detrusor muscle relaxation and a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Mirabig 50mg Extended-Release Tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Extended-release Mirabig 50mg tablets may pose pregnancy risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Mirabig 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Mirabig 50mg Extended-Release Tablets.
KidneyCAUTION
Extended-release Mirabig 50mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification of Mirabig 50mg extended-release tablets may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with liver impairment should use Mirabig 50mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. Mirabig 50mg Extended-Release tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Mirabig 50mg Tablet ER :
Should you forget a Mirabig 50mg Extended-Release Tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mirabig 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Anilide-based compound |
| Developing Habits | No. |
| Treatment Category | Urology |
| Action Class | Beta-3 agonist for bladder control |






